申请人:MEMORIAL SLOAN KETTERING CANCER CENTER
公开号:WO2018175844A1
公开(公告)日:2018-09-27
The invention relates to novel spiroketal antioxidants, including compounds of Formula (I) and (II). The compounds have antioxidant properties and are useful for the treatment and/or prevention of diseases and conditions associated with oxidative stress in the body (e.g., metabolic conditions, neurodegenerative diseases, cardiovascular diseases, inflammatory diseases, autoimmune diseases, proliferative diseases, renal diseases). The invention provides pharmaceutical compositions comprising the compounds, and kits comprising the same. Additionally, the invention provides uses of the compounds described herein (e.g., for inhibiting the concentration or production of reactive oxygen species (ROS), inhibiting the concentration or production of reactive nitrogen species (RNS), reducing oxidative stress, inhibiting NADPH oxidase activity, and for slowing or reducing the effects of aging).
本发明涉及新型螺环酮类抗氧化剂,包括式(I)和式(II)的化合物。这些化合物具有抗氧化性质,可用于治疗和/或预防与体内氧化应激相关的疾病和病况(例如代谢病、神经退行性疾病、心血管疾病、炎症性疾病、自身免疫疾病、增生性疾病、肾脏疾病)。本发明提供包括这些化合物的制药组合物和包含相同化合物的试剂盒。此外,本发明提供了本文所述化合物的用途(例如用于抑制反应性氧化物种(ROS)的浓度或生产、抑制反应性氮物种(RNS)的浓度或生产、减少氧化应激、抑制NADPH氧化酶活性以及减缓或减少衰老的影响)。